Chief Executive Officer, JSC “Pharmstandart”
Since 2003, Igor Krilov has been general director of ACN, which subsequently became Pharmstandard. He develops and realizes the company’s strategy, is involved in the operational management of the holding’s five businesses. He oversaw the acquisition and integration of the Tyumen medical equipment and instrument factory and the Masterlek pharmaceutical company. In May 2007, Pharmstandard undertook the first overseas equity placement of a Russian pharmaceutical-industry company.
Since 1994, he has had a managing role at Eli Lilly and Aventis Pharma.
He graduated with honors from the Kirov Military-Medical Academy, where he specialized in “medical affairs”. He served in the armed forces for 13 years.